Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Applied Imaging Corp.

This article was originally published in The Gray Sheet

Executive Summary

Acquisition of the Perceptive Scientific Instruments genetic imaging business of International Remote Imaging Systems for $1.35 mil. in Applied Imaging Corp. stock is noted in a recent 8-K filing with the Securities and Exchange Commission. IRIS previously had agreed to sell PSI to an undisclosed company for $2.5-5 mil. in cash, but that deal fell through when the government did not approve the transfer of their research contracts to the potential buyer. "PSI provides us with a strong position among large clinical reference laboratories, complementing our well-established strength in hospital and research genetics laboratories," Applied Imaging Chairman and CEO Jack Goldstein explains in a July 6 release announcing the deal

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013588

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel